Hong Kong-based life sciences venture capital (VC) firm Delos Capital has reached the first closing of its Fund III at $300 million with support from investors across the US and Greater China.
Read more: https://bit.ly/3GPszsl
HK-based life sciences VC Delos Capital holds first close of Fund III at $300m
Comments are closed.